期刊文献+

椎管内阻滞下丙泊酚镇静导致不良反应的因素

Factors of Adverse Reactions Induced by Propofol Sedation during Intraspinal Block
下载PDF
导出
摘要 丙泊酚是一种起效快、作用时间短、恢复迅速的镇静药,因镇静和一定的镇痛作用已经成为全身麻醉诱导术中维持椎管内阻滞期间清醒镇静的首选药物,目前已经在世界范围内得到广泛的应用。但是在丙泊酚镇静期间,各种原因导致的丙泊酚不良反应时有发生。丙泊酚导致的不良反应主要有血流动力学反应(如血压、心率下降)、呼吸抑制、镇静过深、过敏反应、注射痛、丙泊酚输注综合征以及术后认知功能改变等。丙泊酚镇静不良反应的发生与程度取决于患者的性别、年龄、疾病状态以及美国麻醉医师协会分级等因素。 Propofol is a kind of sedative with quick effect,short action time and rapid recovery. Because of sedation and certain analgesic effect,it has become the first choice drug of conscious sedation during intraspinal block in general anesthesia induction,and has been widely used in the world. However,during the sedation of propofol,adverse reactions of propofol caused by various reasons occur from time to time,which mainly include hemodynamic reaction( such as blood pressure,heart rate reduction),respiratory depression,too deep sedation,hypersensitivity,injection pain,propofol infusion syndrome and postoperative cognitive function changes. The occurrence and degree of sedative adverse reactions of propofol depend on the patient’s gender,age,disease status and the American Society of Anesthesiologists classification.
作者 张铧文 孙波 李恩有 ZHANG Huawen;SUN Bo;LI Enyou(Department of Anesthesia,the First Affiliated Hospital of Harbin Medical University,Harbin 150001,China)
出处 《医学综述》 2020年第9期1814-1818,共5页 Medical Recapitulate
关键词 丙泊酚 椎管内阻滞 镇静 不良反应 Propofol Intraspinal block Sedation Adverse reaction
  • 相关文献

参考文献2

二级参考文献24

  • 1Irwin MG, Hui TW, Milne SE, Kenny GN. Propofol effective concentration 50 and its relationship to bispectral index. Anaesthesia 2002, 57: 242-8.
  • 2Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJM,Gambus PL, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil.Ⅰ. Model development. Anesthesiology 1997, 86: 10-23.
  • 3Jacobs JR, Reves JG, Marty J, White WD, Bai SA, Smith LR.Aging increases pharmacodynamic sensitivity to the hypnotic effects of midazolam. Anesth Analg 1995, 80: 143-8.
  • 4Schuttler J, Ihmsen H. Population pharmacokinetics of propofol:a multicenter study. Anesthesiology 2000, 92: 727-38.
  • 5Li YH, Rui JZ, Zhou YG, Wang LQ, Fu SE, Yang J J, et al. Population pharmacokinetics of propofol in Chinese patients. Acta Pharmacol Sin 2003, 24: 581-8.
  • 6Knibbe CA, Zuideveld KE Aarts LP, Kuks PF, Danhof M. Pharmacokinetics and effects of propofol 6% for short-term sedation in paediatric patients following cardiac surgery. Br J Clin Pharmacol 2002, 54: 415-22.
  • 7Kearse LA Jr, Rosow C, Zaslavsky A, Connors P, Dershwitz M,Denman W. Bispectral analysis of electroencephalogram predicts conscious processing of information during propofol sedation and hypnosis. Anaesthesiology 1998, 88: 25-34.
  • 8Malinga M, Peitflaux F, Lepage JY, Malinovsky J, Cozian A,Pinaud M. Dose-response relationship between target-controlled concentration of propofol and bispectral index. Br J Anaesth 1998, 80 Suppl- A132.
  • 9Li YH, Bao FP, Zhu SM, Xu JG. Determination of propofol in cerebral spinal fluid by HPLC with fluorescence detection. J Zhejiang Univ (Medical Science) 2006, 35: 87-90.
  • 10Beal SL, Sheiner LB. NONMEM user's guide. San Francisco:University of California San Francisco, 1998.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部